Pfister DG - Search Results

1

A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.

Ho AL, Lipson BL, Sherman EJ, Xiao H, Fury MG, Apollo A, Seetharamu N, Sima CS, Haque S, Lyo JK, Sales R, Cox L, Pfister DG. Ho AL, et al. Among authors: pfister dg. Invest New Drugs. 2014 Jun;32(3):549-54. doi: 10.1007/s10637-014-0073-x. Epub 2014 Feb 25. Invest New Drugs. 2014. PMID: 24566705 Clinical Trial.

2

Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer.

Harrison LB, Pfister DG, Fass DE, Armstrong JG, Sessions RB, Shah JP, Spiro RH, Strong EW, Weisen S, Bosl GJ. Harrison LB, et al. Among authors: pfister dg. Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):703-8. doi: 10.1016/0360-3016(91)90689-2. Int J Radiat Oncol Biol Phys. 1991. PMID: 1869464

3

Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer.

Tavorath R, Pfister DG. Tavorath R, et al. Among authors: pfister dg. Curr Opin Oncol. 1995 May;7(3):242-7. doi: 10.1097/00001622-199505000-00009. Curr Opin Oncol. 1995. PMID: 7654826 Review.

4

Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer.

Pfister DG, Bajorin D, Motzer R, Scher H, Louison C, Harrison L, Shah J, Strong E, Bosl G. Pfister DG, et al. Arch Otolaryngol Head Neck Surg. 1994 Jan;120(1):89-95. doi: 10.1001/archotol.1994.01880250077011. Arch Otolaryngol Head Neck Surg. 1994. PMID: 8274261 Clinical Trial.

5

A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer.

Pfister DG, Bajorin D, Motzer RJ, Scher H, Louison C, Harrison L, Shah J, Strong E, Bosl G. Pfister DG, et al. Invest New Drugs. 1993 Feb;11(1):53-6. doi: 10.1007/BF00873911. Invest New Drugs. 1993. PMID: 8349436 Clinical Trial.

6

The role of chemotherapy in the curative treatment of head and neck cancer.

Pfister DG, Shaha AR, Harrison LB. Pfister DG, et al. Surg Oncol Clin N Am. 1997 Oct;6(4):749-68. Surg Oncol Clin N Am. 1997. PMID: 9309092 Review.

7

Clinical economics of head and neck malignancies.

Sherman EJ, Ruchlin HS, Holden JS, Pfister DG. Sherman EJ, et al. Among authors: pfister dg. Hematol Oncol Clin North Am. 1999 Aug;13(4):867-81. doi: 10.1016/s0889-8588(05)70098-8. Hematol Oncol Clin North Am. 1999. PMID: 10494519 Review.

8

The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.

Sherman EJ, Pfister DG, Ruchlin HS, Rubin DM, Radzyner MH, Kelleher GH, Slovin SF, Kelly WK, Scher HI. Sherman EJ, et al. Among authors: pfister dg. Cancer. 2001 Feb 15;91(4):841-53. Cancer. 2001. PMID: 11241254 Clinical Trial.

9

A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: where does it fit among available treatment options?

Pfister DG, Sherman EJ, Wolden SL. Pfister DG, et al. Cancer Invest. 2001;19(2):217-8. doi: 10.1081/cnv-100000157. Cancer Invest. 2001. PMID: 11296625 No abstract available.

10

Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.

Laurie SA, Pfister DG, Kris MG, Tong WP, Chronowski G, Pisters KM, Heelan RT, Sirotnak FM. Laurie SA, et al. Among authors: pfister dg. Clin Cancer Res. 2001 Mar;7(3):501-9. Clin Cancer Res. 2001. PMID: 11297240 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters